Back
Delegates Premium Access

Dual or single anti-thrombotic therapy in patients with atrial fibrillation after TAVI: a pre-specified analysis from the ENVISAGE-TAVI AF trial

Session: Poster session (2) - Pharmacology and pharmacotherapy
Topic: Antiplatelet Drugs
Speaker: Professor M. Valgimigli (Lugano, CH)
Event: EAPCI Summit 2026

Congress Presentation

Add to my library

Like

About the speaker

Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)
37 presentations
7 followers

4 more presentations in this session

Sex differences among elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention receiving ticagrelor 60 mg vs. 90 mg: a post-hoc analysis of a randomized trial

Speaker: Doctor A. Laino (Naples, IT)

Access
Abstract
Like
Thumbnail

Clopidogrel versus aspirin as long-term monotherapy after PCI with drug-eluting stents: a systematic review and meta-analysis

Speaker: Doctor A. Emara (Menoufia, EG)

Access
Abstract
Like
Thumbnail

Plasma metabolomic profiling of patients with acute coronary syndrome treated with potent platelet inhibitors

Speaker: Mr J. Rogozarski (Vienna, AT)

Access
Abstract
Like
Thumbnail

Discussant - Pharmacology and pharmacotherapy

Access
Like
Thumbnail

Access the full session

Poster session (2) - Pharmacology and pharmacotherapy

Speakers: Professor M. Valgimigli, Doctor A. Laino, Doctor A. Emara, Mr J. Rogozarski
Access
Like
Thumbnail

About the event

Image

EAPCI Summit 2026

19 February - 20 February 2026

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources